China Legislates Towards Green Drug Sector
This article was originally published in PharmAsia News
China will begin assessing taxes on polluting industries, particularly pharma, and will increase supervision to ensure all trade products are manufactured in eco-friendly processes,
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.